ArticleJournal for immunotherapy of cancer2020

Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy.

Koji Nagaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.